Source: BEFREE
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 2007 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2007 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2008 | 2018 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 1998 | 2015 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2012 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2011 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2007 | 2018 | ||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 | |||||||||
|
basic transcription factor 3 pseudogene 11 | 0.519 | 0.731 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2017 | |||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2018 | ||||||||
|
growth differentiation factor 15 | 0.429 | 0.808 | 3.0E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2019 | ||||||||
|
bone morphogenetic protein 2 | 0.432 | 0.846 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2000 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2018 | ||||||||
|
PDZ and LIM domain 3 | 0.547 | 0.769 | 3.0E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
attractin like 1 | 0.546 | 0.769 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2020 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2009 | 2018 | ||||||||
|
N-acetyltransferase 10 | 0.536 | 0.769 | 4.1E-22 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
periostin | 0.428 | 0.885 | 1.1E-09 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2018 | ||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | |||||||||
|
cathepsin K | 0.497 | 0.808 | 3.1E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2018 |